AC Immune SA ($ACIU) rose on April 08, 2026. Here's the breakdown of what drove the move and what traders are watching next.
What Happened
Biotech screener spike: +15.19% with 607k volume; Alzheimer's/neurodegeneration focus
The Bull Case
Potential clinical trial catalyst; biotech sector rotation into small-cap plays; insider filings suggest activity; high-risk/high-reward profile
The Bear Case
Micro-cap ($316.5M); binary clinical outcomes; pharma development risk; illiquidity; sector sentiment fragile if rates rise further
Price Target & What to Watch
N/A (clinical-stage biotech; no consensus target)